Search Results - "Emma Civit"
-
1
Active lupus in Argentina: Results of a multicenter and national registry
Published in Lupus (01-11-2023)“…Objective To evaluate the association between patients’ characteristics and disease activity in an Argentine lupus registry. Methods Cross-sectional study…”
Get full text
Journal Article -
2
Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease‐related factors
Published in International journal of rheumatic diseases (01-11-2018)“…Objective To study the prevalence and the associated factors of work disability (WD) in systemic lupus erythematosus (SLE) patients. Methods A sample of 419…”
Get full text
Journal Article -
3
Sobrevida, eficacia y seguridad de Golimumab en pacientes con Artritis Reumatoidea y Espondiloartritis: datos de una cohorte argentina
Published in Revista argentina de reumatologiá (Buenos Aires, Argentina : 1990) (01-06-2021)“…Objetivos: golimumab ha sido aprobado para el tratamiento de pacientes con artritis reumatoidea (AR), artritis psoriásica (APs) y espondiloartritis axial. Sin…”
Get full text
Journal Article -
4
Multicenter lupus register from Argentina, the RELESSAR database: Influence of ethnicity on disease phenotype
Published in Lupus (01-04-2022)“…Objective The objective is to describe the main characteristics of patients with systemic lupus erythematosus (SLE) in Argentina and to examine the influence…”
Get full text
Journal Article -
5
Rheumatoid arthritis monotherapy in the Jak inhibitors Era. Current prevalence and associated factors in a multicenter study
Published in ARP rheumatology (01-01-2023)“…Combined therapy constitutes the standard of care in RA. Jak inhibitors (Jaki) have shown efficacy in monotherapy, a modality used in cases where it is not…”
Get more information
Journal Article -
6
Survival, efficacy and safety of Golimumab in patients with Rheumatoid Arthritis and Spondyloarthritis: data from an Argentine cohort
Published in Revista argentina de reumatologiá (Buenos Aires, Argentina : 1990) (01-06-2021)“…Objectives: golimumab is approved for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis. However, data from our…”
Get full text
Journal Article -
7
Frecuencia de eventos cardiovasculares en pacientes con lupus eritematoso sistémico. Datos del registro RELESSAR transversal
Published in Revista argentina de reumatologiá (Buenos Aires, Argentina : 1990) (30-06-2023)“…Introducción: el progreso en los tratamientos para el lupus eritematoso sistémico (LES) resultó en una disminución de la mortalidad; sin embargo, la enfermedad…”
Get full text
Journal Article -
8
Lupus en Argentina. Pacientes no respondedores al tratamiento estándar y belimumab como posible opción. Datos del registro RELESSAR
Published in Revista argentina de reumatologiá (Buenos Aires, Argentina : 1990) (09-03-2022)“…Introducción: el lupus es una enfermedad compleja y varias veces de difícil abordaje. Alcanzar la remisión es uno de los objetivos, incorporando opciones…”
Get full text
Journal Article -
9
TNFα-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry
Published in Reumatología clinica (01-10-2024)Get full text
Journal Article